MAYBAKER Notifies of Contract Manufacturing Agreement with Sanofi Nigeria Limited

Wednesday, December 18, 2019 / 03:12 PM / NSE/ Header Image Credit: @maybakernigeria

May & Baker Nigeria Plc - a leading pharmaceutical manufacturing and the first pharmaceutical company in Nigeria hereby announces the signing of a contract manufacturing agreement with Sanofi Nigeria Limited - a subsidiary of the French Pharmaceutical giant - Sanofi.

Under the agreement May & Baker would use her World Health Organisation (WHO) certified manufacturing facility to produce four product brands of Sanofi for sale in Nigeria and the West African market.

This agreement not only serves as a direct response to the call by the National Agency for Food and Drugs Administration and Control (NAFDAC) for pharmaceutical brand owners to localise their production by using locally available capacity to produce quality products in Nigeria but also a step forward in Nigeria's quest for medicine security and self-sufficiency.

The products which May & Baker would manufacture for Sanofi include Flagyl tablets and Suspension and Tarivid tablets, anti-infective medicines and Malareich tablets - an anti-malaria drug.

May & Baker Nigeria Plc has invested heavily in setting up internationally standard production facility and obtain WHO Good Manufacturing Practice (GMP) certification to enable her extend services to other products owners who might wish to heed the call to localise their medicine production in Nigeria. May & Baker facility has capacity to produce six billion tablets and 37.5 million 60ml liquid medicines annually.

May & Baker is the first pharmaceutical Manufacturing Company in Nigeria founded on September 4, 1944. The company went through different ownerships of foreign multinationals but became fully indigenous in 2002. It was listed on the Nigerian Stock Exchange in 1994 where it has won the coveted award of sectoral leadership of Healthcare sector six times.

In 2008, the company was awarded the International Organization for Standardization (ISO) Quality Management Certificate, in recognition of the conformity of her management system to best international standards. This was further upgraded in 2017 to NIS ISO 9001:2015. The company has won several other awards including the PMG-MAN awards for the attainment of WHO GMP.

In 2018, May & Baker also won the highly coveted National Rroductivity Order of Merit award.

Visit  May & Baker Nigeria Plc IR Page in Proshare MARKETS

Graph - One Year Share Price Movement

Table: Unaudited Q3 2019 Results

Related News

1.           MAYBAKER Declares N473.577m PAT in Q3 2019 Results,(SP:N2.00k)

2.           MAYBAKER Declares N290.83m PAT in Q2 2019 Results,(SP:N2.00k)

3.       MAYBAKER Notifies of Notifies of Late Filing of the Company's Q2 2019 Financial Statements

4.           MAYBAKER Notifies of the Resolutions passed at the 68th AGM of the Company

5.           MAYBAKER Declares N133.59million PAT in Q1'19 Results,(SP:N2.27k)

6.   MAYBAKER Declares N585.20 million PAT in 2018 Audited Results; Proposes N0.20K Final Dividend

7.           MAYBAKER Declares N744.330m PAT in Q3 2018 Results,(SP:N2.50k)

8.           MAYBAKER Declares N264.45m PAT in Q2 2018 Results,(SP:N2.45k)